Skip to main content
TipRanks
Go Ultimate75% OFF

NervGen Pharma (NGEN) Stock Forecast & Price Target

143 Followers
See the Price Targets and Ratings of:

NGEN Analyst Ratings

Moderate Buy
2Ratings
2Buy0Hold0Sell
Based on 2 analysts giving stock ratings to NervGen Pharma in the past 3 months

NGEN Stock 12 Month Forecast

$8.00▲(316.67% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for NervGen Pharma in the last 3 months. The average price target is $8.00 with a high forecast of $10.00 and a low forecast of $6.00. The average price target represents a 316.67% change from the last price of $1.92.
Highest Price Target$10.00Average Price Target$8.00Lowest Price Target$6.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for NGEN
Price TargetArticle
Stifel Nicolaus$6buy212.50%UpsideReiterated11/19/26
Leerink Partners$10buy420.83%UpsideReiterated11/17/26
TD Cowen―buy―Reiterated08/13/26
H.C. Wainwright$18→$15buy681.25%UpsideReiterated07/14/26
Lucid Capital$18buy837.50%UpsideInitiated04/15/26
Research Capital$5.50buy186.46%UpsideReiterated04/10/26
Maxim Group$10→$12buy525.00%UpsideAssigned04/09/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PALIPalisade Bio
RZLTRezolute
MDWDMediwound
OVIDOvid Therapeutics
DFTXDefinium Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering NervGen Pharma

3 Months
Justin Keywood
Justin KeywoodStifel Nicolaus
Success Rate4/12 ratings generated profit
33%
Average Return
-10.27%

Copying Justin Keywood's trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -10.27% per trade.

1 Year
Justin Keywood
Justin KeywoodStifel Nicolaus
Success Rate6/12 ratings generated profit
50%
Average Return
+8.97%

Copying Justin Keywood's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +8.97% per trade.

2 Years
Justin Keywood
Justin KeywoodStifel Nicolaus
Success Rate2/12 ratings generated profit
17%
Average Return
-6.36%

Copying Justin Keywood's trades and holding each position for 2 Years would result in 16.67% of your transactions generating a profit, with an average return of -6.36% per trade.

NGEN Analyst Recommendation Trends

05101520Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for NGEN
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy54213
Buy12110
Hold00000
Sell00000
Strong Sell00000
total66323

In the current month, NGEN has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. NGEN average Analyst price target in the past 3 months is 8.00.

NGEN Financial Forecast

$-2$-1.5$-1$-0.5$0Q4 2025Q3 2026Q4 2026
High$-0.08
Consensus$-0.08
Low$-0.08

NGEN Earnings Forecast

Next quarter’s earnings estimate for NGEN is -$0.08 with a range of -$0.08 to -$0.08. The previous quarter’s EPS was -$0.04. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$-1$-0.5$0$0.5$1Q4 2025Q3 2026Q4 2026
High$0.00
Consensus$0.00
Low$0.00

NGEN Sales Forecast

Next quarter’s sales forecast for NGEN is $0 with a range of $0 to $0. The previous quarter’s sales results were $0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

NGEN Stock Forecast FAQ

What is NGEN’s average 12-month price target, according to analysts?
Based on analyst ratings, NervGen Pharma’s 12-month average price target is $8.00.
What is NGEN’s upside potential, based on the analysts’ average price target?
NervGen Pharma has 316.67% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is NGEN a Buy, Sell or Hold?
NervGen Pharma has a consensus rating of Moderate Buy which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is NervGen Pharma’s price target?
The average price target for NervGen Pharma is $8.00. This is based on 2 12-month price targets, issued in the past 3 months. The highest analyst price target is $10.00, the lowest forecast is $6.00. The average price target represents a 316.67% increase from the current price of $1.92.
What do analysts say about NervGen Pharma?
NervGen Pharma’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Street analysts.
How can I buy shares of NGEN?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.